nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ADRA2A—epilepsy syndrome	0.0548	0.306	CbGaD
Trazodone—SLC6A4—epilepsy syndrome	0.0418	0.233	CbGaD
Trazodone—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0376	0.12	CpDpCtD
Trazodone—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0376	0.12	CpDpCtD
Trazodone—HTR2A—epilepsy syndrome	0.0321	0.179	CbGaD
Trazodone—bipolar disorder—Topiramate—epilepsy syndrome	0.0319	0.102	CpDpCtD
Trazodone—Loxapine—Clobazam—epilepsy syndrome	0.031	0.196	CrCrCtD
Trazodone—endogenous depression—Valproic Acid—epilepsy syndrome	0.0305	0.0974	CpDpCtD
Trazodone—CYP2D6—epilepsy syndrome	0.0294	0.164	CbGaD
Trazodone—Clozapine—Clonazepam—epilepsy syndrome	0.0291	0.184	CrCrCtD
Trazodone—Loxapine—Diazepam—epilepsy syndrome	0.0288	0.182	CrCrCtD
Trazodone—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0285	0.091	CpDpCtD
Trazodone—schizophrenia—Lamotrigine—epilepsy syndrome	0.0272	0.0868	CpDpCtD
Trazodone—Clozapine—Clobazam—epilepsy syndrome	0.0266	0.168	CrCrCtD
Trazodone—Clozapine—Diazepam—epilepsy syndrome	0.0247	0.157	CrCrCtD
Trazodone—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0242	0.0773	CpDpCtD
Trazodone—bipolar disorder—Clonazepam—epilepsy syndrome	0.0228	0.0727	CpDpCtD
Trazodone—ABCB1—epilepsy syndrome	0.021	0.117	CbGaD
Trazodone—schizophrenia—Carbamazepine—epilepsy syndrome	0.0206	0.0658	CpDpCtD
Trazodone—bipolar disorder—Gabapentin—epilepsy syndrome	0.0183	0.0586	CpDpCtD
Trazodone—Prochlorperazine—Clobazam—epilepsy syndrome	0.0178	0.113	CrCrCtD
Trazodone—schizophrenia—Valproic Acid—epilepsy syndrome	0.0175	0.0559	CpDpCtD
Trazodone—schizophrenia—Clonazepam—epilepsy syndrome	0.0165	0.0526	CpDpCtD
Trazodone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00994	0.0518	CbGbCtD
Trazodone—CYP3A7—Carbamazepine—epilepsy syndrome	0.00832	0.0433	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00832	0.0433	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00746	0.0389	CbGbCtD
Trazodone—CYP3A7—Phenytoin—epilepsy syndrome	0.00746	0.0389	CbGbCtD
Trazodone—ABCB1—Levetiracetam—epilepsy syndrome	0.00707	0.0368	CbGbCtD
Trazodone—CYP3A7—Phenobarbital—epilepsy syndrome	0.00665	0.0346	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00665	0.0346	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00656	0.0342	CbGbCtD
Trazodone—CYP3A7—Midazolam—epilepsy syndrome	0.00656	0.0342	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00631	0.0328	CbGbCtD
Trazodone—CYP3A7—Diazepam—epilepsy syndrome	0.00631	0.0328	CbGbCtD
Trazodone—CYP3A5—Carbamazepine—epilepsy syndrome	0.00624	0.0325	CbGbCtD
Trazodone—CYP3A5—Phenytoin—epilepsy syndrome	0.0056	0.0292	CbGbCtD
Trazodone—CYP3A5—Phenobarbital—epilepsy syndrome	0.00499	0.026	CbGbCtD
Trazodone—CYP3A5—Midazolam—epilepsy syndrome	0.00492	0.0256	CbGbCtD
Trazodone—ABCB1—Clobazam—epilepsy syndrome	0.0049	0.0255	CbGbCtD
Trazodone—CYP3A5—Diazepam—epilepsy syndrome	0.00473	0.0246	CbGbCtD
Trazodone—ABCB1—Lamotrigine—epilepsy syndrome	0.00472	0.0246	CbGbCtD
Trazodone—ABCB1—Carbamazepine—epilepsy syndrome	0.00406	0.0212	CbGbCtD
Trazodone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00388	0.0202	CbGbCtD
Trazodone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00373	0.0194	CbGbCtD
Trazodone—ABCB1—Phenytoin—epilepsy syndrome	0.00364	0.019	CbGbCtD
Trazodone—CYP3A4—Felbamate—epilepsy syndrome	0.0036	0.0188	CbGbCtD
Trazodone—CYP3A4—Trimethadione—epilepsy syndrome	0.0036	0.0188	CbGbCtD
Trazodone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00339	0.0176	CbGbCtD
Trazodone—ABCB1—Phenobarbital—epilepsy syndrome	0.00325	0.0169	CbGbCtD
Trazodone—ABCB1—Midazolam—epilepsy syndrome	0.0032	0.0167	CbGbCtD
Trazodone—CYP2D6—Propofol—epilepsy syndrome	0.0032	0.0167	CbGbCtD
Trazodone—ABCB1—Diazepam—epilepsy syndrome	0.00308	0.016	CbGbCtD
Trazodone—CYP3A4—Clonazepam—epilepsy syndrome	0.00306	0.016	CbGbCtD
Trazodone—CYP3A4—Clobazam—epilepsy syndrome	0.00294	0.0153	CbGbCtD
Trazodone—CYP3A4—Rufinamide—epilepsy syndrome	0.0025	0.013	CbGbCtD
Trazodone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00243	0.0127	CbGbCtD
Trazodone—CYP3A4—Primidone—epilepsy syndrome	0.00227	0.0118	CbGbCtD
Trazodone—CYP3A4—Phenytoin—epilepsy syndrome	0.00218	0.0114	CbGbCtD
Trazodone—HTR2A—phrenic nerve—epilepsy syndrome	0.00213	0.0996	CbGeAlD
Trazodone—CYP3A4—Propofol—epilepsy syndrome	0.00204	0.0106	CbGbCtD
Trazodone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00195	0.0101	CbGbCtD
Trazodone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00195	0.0101	CbGbCtD
Trazodone—CYP3A4—Midazolam—epilepsy syndrome	0.00192	0.00999	CbGbCtD
Trazodone—CYP3A4—Diazepam—epilepsy syndrome	0.00184	0.00961	CbGbCtD
Trazodone—CYP3A4—Zonisamide—epilepsy syndrome	0.0018	0.00938	CbGbCtD
Trazodone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00145	0.00757	CbGbCtD
Trazodone—CYP3A4—Topiramate—epilepsy syndrome	0.00131	0.00683	CbGbCtD
Trazodone—HTR2A—locus ceruleus—epilepsy syndrome	0.00095	0.0445	CbGeAlD
Trazodone—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000898	0.0421	CbGeAlD
Trazodone—HTR2A—cerebellar cortex—epilepsy syndrome	0.000774	0.0363	CbGeAlD
Trazodone—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000756	0.0354	CbGeAlD
Trazodone—HTR2A—vagus nerve—epilepsy syndrome	0.000727	0.0341	CbGeAlD
Trazodone—HTR2C—ganglion—epilepsy syndrome	0.000559	0.0262	CbGeAlD
Trazodone—HTR2A—pons—epilepsy syndrome	0.000547	0.0256	CbGeAlD
Trazodone—SLC6A4—ganglion—epilepsy syndrome	0.00053	0.0248	CbGeAlD
Trazodone—HTR2A—autonomic nervous system—epilepsy syndrome	0.000505	0.0236	CbGeAlD
Trazodone—HTR1A—ganglion—epilepsy syndrome	0.00047	0.022	CbGeAlD
Trazodone—HTR2A—telencephalic ventricle—epilepsy syndrome	0.00045	0.0211	CbGeAlD
Trazodone—SLC6A4—hindbrain—epilepsy syndrome	0.000402	0.0188	CbGeAlD
Trazodone—HTR1A—hindbrain—epilepsy syndrome	0.000357	0.0167	CbGeAlD
Trazodone—ADRA1A—hindbrain—epilepsy syndrome	0.000329	0.0154	CbGeAlD
Trazodone—HTR2A—ganglion—epilepsy syndrome	0.00028	0.0131	CbGeAlD
Trazodone—HTR2C—brainstem—epilepsy syndrome	0.000243	0.0114	CbGeAlD
Trazodone—HTR2C—forebrain—epilepsy syndrome	0.000234	0.011	CbGeAlD
Trazodone—SLC6A4—brainstem—epilepsy syndrome	0.00023	0.0108	CbGeAlD
Trazodone—SLC6A4—forebrain—epilepsy syndrome	0.000222	0.0104	CbGeAlD
Trazodone—HTR2B—forebrain—epilepsy syndrome	0.00022	0.0103	CbGeAlD
Trazodone—HTR2C—telencephalon—epilepsy syndrome	0.000216	0.0101	CbGeAlD
Trazodone—HTR2A—hindbrain—epilepsy syndrome	0.000213	0.00996	CbGeAlD
Trazodone—HTR1A—brainstem—epilepsy syndrome	0.000204	0.00958	CbGeAlD
Trazodone—SLC6A4—telencephalon—epilepsy syndrome	0.000204	0.00957	CbGeAlD
Trazodone—HTR2B—telencephalon—epilepsy syndrome	0.000202	0.00949	CbGeAlD
Trazodone—HTR1A—forebrain—epilepsy syndrome	0.000197	0.00924	CbGeAlD
Trazodone—CYP2D6—hindbrain—epilepsy syndrome	0.000194	0.00907	CbGeAlD
Trazodone—ADRA1A—brainstem—epilepsy syndrome	0.000188	0.00883	CbGeAlD
Trazodone—ADRA1A—forebrain—epilepsy syndrome	0.000182	0.00852	CbGeAlD
Trazodone—HTR1A—telencephalon—epilepsy syndrome	0.000181	0.0085	CbGeAlD
Trazodone—HTR2C—medulla oblongata—epilepsy syndrome	0.000169	0.00793	CbGeAlD
Trazodone—ORM1—spinal cord—epilepsy syndrome	0.000168	0.00787	CbGeAlD
Trazodone—ADRA1A—telencephalon—epilepsy syndrome	0.000167	0.00784	CbGeAlD
Trazodone—HTR2C—midbrain—epilepsy syndrome	0.000155	0.00725	CbGeAlD
Trazodone—HTR2C—spinal cord—epilepsy syndrome	0.000151	0.00708	CbGeAlD
Trazodone—SLC6A4—midbrain—epilepsy syndrome	0.000147	0.00687	CbGeAlD
Trazodone—SLC6A4—spinal cord—epilepsy syndrome	0.000143	0.00671	CbGeAlD
Trazodone—ORM1—nervous system—epilepsy syndrome	0.000142	0.00663	CbGeAlD
Trazodone—HRH1—forebrain—epilepsy syndrome	0.000141	0.0066	CbGeAlD
Trazodone—ADRA2A—forebrain—epilepsy syndrome	0.000138	0.00648	CbGeAlD
Trazodone—ORM1—central nervous system—epilepsy syndrome	0.000136	0.00639	CbGeAlD
Trazodone—HTR2C—head—epilepsy syndrome	0.000134	0.00629	CbGeAlD
Trazodone—HTR1A—midbrain—epilepsy syndrome	0.00013	0.0061	CbGeAlD
Trazodone—HRH1—telencephalon—epilepsy syndrome	0.000129	0.00607	CbGeAlD
Trazodone—HTR2C—nervous system—epilepsy syndrome	0.000127	0.00596	CbGeAlD
Trazodone—SLC6A4—head—epilepsy syndrome	0.000127	0.00596	CbGeAlD
Trazodone—ADRA2A—telencephalon—epilepsy syndrome	0.000127	0.00596	CbGeAlD
Trazodone—HTR1A—spinal cord—epilepsy syndrome	0.000127	0.00596	CbGeAlD
Trazodone—HTR2B—head—epilepsy syndrome	0.000126	0.00591	CbGeAlD
Trazodone—HTR2C—central nervous system—epilepsy syndrome	0.000123	0.00574	CbGeAlD
Trazodone—HTR2A—brainstem—epilepsy syndrome	0.000122	0.00571	CbGeAlD
Trazodone—SLC6A4—nervous system—epilepsy syndrome	0.000121	0.00565	CbGeAlD
Trazodone—HTR2B—nervous system—epilepsy syndrome	0.00012	0.0056	CbGeAlD
Trazodone—HTR2A—forebrain—epilepsy syndrome	0.000118	0.00551	CbGeAlD
Trazodone—SLC6A4—central nervous system—epilepsy syndrome	0.000116	0.00544	CbGeAlD
Trazodone—HTR2B—central nervous system—epilepsy syndrome	0.000115	0.00539	CbGeAlD
Trazodone—HTR1A—head—epilepsy syndrome	0.000113	0.00529	CbGeAlD
Trazodone—CYP2D6—brainstem—epilepsy syndrome	0.000111	0.0052	CbGeAlD
Trazodone—HTR2A—telencephalon—epilepsy syndrome	0.000108	0.00507	CbGeAlD
Trazodone—CYP2D6—forebrain—epilepsy syndrome	0.000107	0.00502	CbGeAlD
Trazodone—HTR1A—nervous system—epilepsy syndrome	0.000107	0.00502	CbGeAlD
Trazodone—ADRA1A—head—epilepsy syndrome	0.000104	0.00488	CbGeAlD
Trazodone—HTR1A—central nervous system—epilepsy syndrome	0.000103	0.00483	CbGeAlD
Trazodone—HTR1A—cerebellum—epilepsy syndrome	0.000101	0.00472	CbGeAlD
Trazodone—ADRA2A—medulla oblongata—epilepsy syndrome	9.99e-05	0.00468	CbGeAlD
Trazodone—ADRA1A—nervous system—epilepsy syndrome	9.87e-05	0.00463	CbGeAlD
Trazodone—CYP2D6—telencephalon—epilepsy syndrome	9.85e-05	0.00461	CbGeAlD
Trazodone—HTR2C—brain—epilepsy syndrome	9.73e-05	0.00456	CbGeAlD
Trazodone—ADRA1A—central nervous system—epilepsy syndrome	9.51e-05	0.00445	CbGeAlD
Trazodone—Vilazodone—SLC6A4—epilepsy syndrome	9.47e-05	0.0459	CrCbGaD
Trazodone—ADRA1A—cerebellum—epilepsy syndrome	9.29e-05	0.00435	CbGeAlD
Trazodone—SLC6A4—brain—epilepsy syndrome	9.22e-05	0.00432	CbGeAlD
Trazodone—HTR2B—brain—epilepsy syndrome	9.14e-05	0.00428	CbGeAlD
Trazodone—ADRA2A—midbrain—epilepsy syndrome	9.13e-05	0.00428	CbGeAlD
Trazodone—ADRA2A—spinal cord—epilepsy syndrome	8.91e-05	0.00417	CbGeAlD
Trazodone—HTR2A—medulla oblongata—epilepsy syndrome	8.5e-05	0.00398	CbGeAlD
Trazodone—HTR1A—brain—epilepsy syndrome	8.19e-05	0.00384	CbGeAlD
Trazodone—HRH1—head—epilepsy syndrome	8.06e-05	0.00378	CbGeAlD
Trazodone—ADRA2A—head—epilepsy syndrome	7.92e-05	0.00371	CbGeAlD
Trazodone—HTR2A—midbrain—epilepsy syndrome	7.76e-05	0.00364	CbGeAlD
Trazodone—ABCB1—forebrain—epilepsy syndrome	7.71e-05	0.00361	CbGeAlD
Trazodone—HRH1—nervous system—epilepsy syndrome	7.64e-05	0.00358	CbGeAlD
Trazodone—HTR2A—spinal cord—epilepsy syndrome	7.58e-05	0.00355	CbGeAlD
Trazodone—ADRA1A—brain—epilepsy syndrome	7.55e-05	0.00354	CbGeAlD
Trazodone—ADRA2A—nervous system—epilepsy syndrome	7.51e-05	0.00352	CbGeAlD
Trazodone—HRH1—central nervous system—epilepsy syndrome	7.36e-05	0.00345	CbGeAlD
Trazodone—Ziprasidone—CHRM3—epilepsy syndrome	7.23e-05	0.0351	CrCbGaD
Trazodone—ADRA2A—central nervous system—epilepsy syndrome	7.23e-05	0.00339	CbGeAlD
Trazodone—ABCB1—telencephalon—epilepsy syndrome	7.09e-05	0.00332	CbGeAlD
Trazodone—ADRA2A—cerebellum—epilepsy syndrome	7.06e-05	0.00331	CbGeAlD
Trazodone—Ziprasidone—CHRM1—epilepsy syndrome	6.75e-05	0.0327	CrCbGaD
Trazodone—HTR2A—head—epilepsy syndrome	6.73e-05	0.00315	CbGeAlD
Trazodone—Vilazodone—CYP2D6—epilepsy syndrome	6.66e-05	0.0323	CrCbGaD
Trazodone—HTR2A—nervous system—epilepsy syndrome	6.38e-05	0.00299	CbGeAlD
Trazodone—HTR2A—central nervous system—epilepsy syndrome	6.15e-05	0.00288	CbGeAlD
Trazodone—CYP2D6—head—epilepsy syndrome	6.13e-05	0.00287	CbGeAlD
Trazodone—HTR2A—cerebellum—epilepsy syndrome	6.01e-05	0.00281	CbGeAlD
Trazodone—CYP3A4—nervous system—epilepsy syndrome	5.91e-05	0.00277	CbGeAlD
Trazodone—HRH1—brain—epilepsy syndrome	5.84e-05	0.00274	CbGeAlD
Trazodone—CYP2D6—nervous system—epilepsy syndrome	5.82e-05	0.00272	CbGeAlD
Trazodone—ADRA2A—brain—epilepsy syndrome	5.74e-05	0.00269	CbGeAlD
Trazodone—CYP3A4—central nervous system—epilepsy syndrome	5.69e-05	0.00267	CbGeAlD
Trazodone—Aripiprazole—CHRM3—epilepsy syndrome	5.65e-05	0.0274	CrCbGaD
Trazodone—CYP2D6—central nervous system—epilepsy syndrome	5.6e-05	0.00262	CbGeAlD
Trazodone—ABCB1—medulla oblongata—epilepsy syndrome	5.57e-05	0.00261	CbGeAlD
Trazodone—Ziprasidone—CHRM2—epilepsy syndrome	5.51e-05	0.0267	CrCbGaD
Trazodone—Ziprasidone—HTR7—epilepsy syndrome	5.48e-05	0.0266	CrCbGaD
Trazodone—CYP2D6—cerebellum—epilepsy syndrome	5.47e-05	0.00256	CbGeAlD
Trazodone—Aripiprazole—CHRM1—epilepsy syndrome	5.27e-05	0.0255	CrCbGaD
Trazodone—ABCB1—midbrain—epilepsy syndrome	5.09e-05	0.00238	CbGeAlD
Trazodone—Clozapine—HRH3—epilepsy syndrome	5.07e-05	0.0246	CrCbGaD
Trazodone—ABCB1—spinal cord—epilepsy syndrome	4.96e-05	0.00233	CbGeAlD
Trazodone—HTR2A—brain—epilepsy syndrome	4.88e-05	0.00229	CbGeAlD
Trazodone—Ziprasidone—ADRA2A—epilepsy syndrome	4.7e-05	0.0228	CrCbGaD
Trazodone—CYP2D6—brain—epilepsy syndrome	4.44e-05	0.00208	CbGeAlD
Trazodone—ABCB1—head—epilepsy syndrome	4.41e-05	0.00207	CbGeAlD
Trazodone—Aripiprazole—CHRM2—epilepsy syndrome	4.3e-05	0.0209	CrCbGaD
Trazodone—Aripiprazole—HTR7—epilepsy syndrome	4.28e-05	0.0208	CrCbGaD
Trazodone—ABCB1—nervous system—epilepsy syndrome	4.18e-05	0.00196	CbGeAlD
Trazodone—ABCB1—central nervous system—epilepsy syndrome	4.03e-05	0.00189	CbGeAlD
Trazodone—Zuclopenthixol—ADRA2A—epilepsy syndrome	3.97e-05	0.0193	CrCbGaD
Trazodone—Hydroxyzine—CYP2D6—epilepsy syndrome	3.96e-05	0.0192	CrCbGaD
Trazodone—Nefazodone—ADRA2A—epilepsy syndrome	3.95e-05	0.0191	CrCbGaD
Trazodone—ABCB1—cerebellum—epilepsy syndrome	3.94e-05	0.00184	CbGeAlD
Trazodone—Prochlorperazine—CHRM2—epilepsy syndrome	3.84e-05	0.0186	CrCbGaD
Trazodone—Aripiprazole—ADRA2A—epilepsy syndrome	3.67e-05	0.0178	CrCbGaD
Trazodone—Loxapine—CHRM3—epilepsy syndrome	3.62e-05	0.0175	CrCbGaD
Trazodone—Ziprasidone—SLC6A4—epilepsy syndrome	3.59e-05	0.0174	CrCbGaD
Trazodone—Quetiapine—CHRM3—epilepsy syndrome	3.53e-05	0.0171	CrCbGaD
Trazodone—Loxapine—CHRM1—epilepsy syndrome	3.38e-05	0.0164	CrCbGaD
Trazodone—Quetiapine—CHRM1—epilepsy syndrome	3.3e-05	0.016	CrCbGaD
Trazodone—ABCB1—brain—epilepsy syndrome	3.2e-05	0.0015	CbGeAlD
Trazodone—Clozapine—CHRM3—epilepsy syndrome	3.04e-05	0.0147	CrCbGaD
Trazodone—Nefazodone—SLC6A4—epilepsy syndrome	3.01e-05	0.0146	CrCbGaD
Trazodone—Fluphenazine—ADRA2A—epilepsy syndrome	2.96e-05	0.0143	CrCbGaD
Trazodone—Clozapine—CHRM1—epilepsy syndrome	2.83e-05	0.0137	CrCbGaD
Trazodone—Aripiprazole—SLC6A4—epilepsy syndrome	2.8e-05	0.0136	CrCbGaD
Trazodone—Trifluoperazine—CHRM2—epilepsy syndrome	2.77e-05	0.0134	CrCbGaD
Trazodone—Ziprasidone—HTR2A—epilepsy syndrome	2.76e-05	0.0134	CrCbGaD
Trazodone—Loxapine—CHRM2—epilepsy syndrome	2.76e-05	0.0134	CrCbGaD
Trazodone—Loxapine—HTR7—epilepsy syndrome	2.74e-05	0.0133	CrCbGaD
Trazodone—Perphenazine—HTR7—epilepsy syndrome	2.73e-05	0.0132	CrCbGaD
Trazodone—Quetiapine—CHRM2—epilepsy syndrome	2.69e-05	0.013	CrCbGaD
Trazodone—Quetiapine—HTR7—epilepsy syndrome	2.68e-05	0.013	CrCbGaD
Trazodone—Domperidone—CYP2D6—epilepsy syndrome	2.55e-05	0.0124	CrCbGaD
Trazodone—Ziprasidone—CYP2D6—epilepsy syndrome	2.52e-05	0.0122	CrCbGaD
Trazodone—Loxapine—ADRA2A—epilepsy syndrome	2.35e-05	0.0114	CrCbGaD
Trazodone—Perphenazine—ADRA2A—epilepsy syndrome	2.34e-05	0.0113	CrCbGaD
Trazodone—Zuclopenthixol—HTR2A—epilepsy syndrome	2.33e-05	0.0113	CrCbGaD
Trazodone—Nefazodone—HTR2A—epilepsy syndrome	2.32e-05	0.0112	CrCbGaD
Trazodone—Clozapine—CHRM2—epilepsy syndrome	2.31e-05	0.0112	CrCbGaD
Trazodone—Clozapine—HTR7—epilepsy syndrome	2.3e-05	0.0112	CrCbGaD
Trazodone—Quetiapine—ADRA2A—epilepsy syndrome	2.3e-05	0.0111	CrCbGaD
Trazodone—Aripiprazole—HTR2A—epilepsy syndrome	2.15e-05	0.0104	CrCbGaD
Trazodone—Zuclopenthixol—CYP2D6—epilepsy syndrome	2.13e-05	0.0103	CrCbGaD
Trazodone—Nefazodone—CYP2D6—epilepsy syndrome	2.12e-05	0.0103	CrCbGaD
Trazodone—Thioproperazine—HTR2A—epilepsy syndrome	2.04e-05	0.00989	CrCbGaD
Trazodone—Clozapine—ADRA2A—epilepsy syndrome	1.98e-05	0.00957	CrCbGaD
Trazodone—Aripiprazole—CYP2D6—epilepsy syndrome	1.97e-05	0.00954	CrCbGaD
Trazodone—Domperidone—ABCB1—epilepsy syndrome	1.82e-05	0.00883	CrCbGaD
Trazodone—Loxapine—SLC6A4—epilepsy syndrome	1.79e-05	0.00869	CrCbGaD
Trazodone—Prochlorperazine—CYP2D6—epilepsy syndrome	1.76e-05	0.00851	CrCbGaD
Trazodone—Fluphenazine—HTR2A—epilepsy syndrome	1.74e-05	0.00841	CrCbGaD
Trazodone—Back pain—Gabapentin—epilepsy syndrome	1.73e-05	0.000179	CcSEcCtD
Trazodone—Headache—Fosphenytoin—epilepsy syndrome	1.73e-05	0.000179	CcSEcCtD
Trazodone—Palpitations—Pregabalin—epilepsy syndrome	1.72e-05	0.000179	CcSEcCtD
Trazodone—Asthenia—Phenytoin—epilepsy syndrome	1.72e-05	0.000179	CcSEcCtD
Trazodone—Nausea—Midazolam—epilepsy syndrome	1.72e-05	0.000178	CcSEcCtD
Trazodone—Hallucination—Topiramate—epilepsy syndrome	1.72e-05	0.000178	CcSEcCtD
Trazodone—Hypoaesthesia—Topiramate—epilepsy syndrome	1.72e-05	0.000178	CcSEcCtD
Trazodone—Tachycardia—Valproic Acid—epilepsy syndrome	1.72e-05	0.000178	CcSEcCtD
Trazodone—Diarrhoea—Zonisamide—epilepsy syndrome	1.72e-05	0.000178	CcSEcCtD
Trazodone—Loss of consciousness—Pregabalin—epilepsy syndrome	1.71e-05	0.000178	CcSEcCtD
Trazodone—Asthenia—Oxcarbazepine—epilepsy syndrome	1.71e-05	0.000178	CcSEcCtD
Trazodone—Pruritus—Clonazepam—epilepsy syndrome	1.71e-05	0.000177	CcSEcCtD
Trazodone—Vomiting—Vigabatrin—epilepsy syndrome	1.71e-05	0.000177	CcSEcCtD
Trazodone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	1.7e-05	0.000176	CcSEcCtD
Trazodone—Pruritus—Phenytoin—epilepsy syndrome	1.7e-05	0.000176	CcSEcCtD
Trazodone—Nausea—Levetiracetam—epilepsy syndrome	1.7e-05	0.000176	CcSEcCtD
Trazodone—Rash—Vigabatrin—epilepsy syndrome	1.7e-05	0.000176	CcSEcCtD
Trazodone—Dizziness—Felbamate—epilepsy syndrome	1.69e-05	0.000176	CcSEcCtD
Trazodone—Dermatitis—Vigabatrin—epilepsy syndrome	1.69e-05	0.000176	CcSEcCtD
Trazodone—Perphenazine—CYP2C19—epilepsy syndrome	1.69e-05	0.0082	CrCbGaD
Trazodone—Pruritus—Oxcarbazepine—epilepsy syndrome	1.69e-05	0.000175	CcSEcCtD
Trazodone—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.69e-05	0.000175	CcSEcCtD
Trazodone—Vision blurred—Gabapentin—epilepsy syndrome	1.68e-05	0.000175	CcSEcCtD
Trazodone—Headache—Vigabatrin—epilepsy syndrome	1.68e-05	0.000175	CcSEcCtD
Trazodone—Hypertension—Pregabalin—epilepsy syndrome	1.68e-05	0.000175	CcSEcCtD
Trazodone—Vomiting—Diazepam—epilepsy syndrome	1.68e-05	0.000174	CcSEcCtD
Trazodone—Anorexia—Valproic Acid—epilepsy syndrome	1.68e-05	0.000174	CcSEcCtD
Trazodone—Tremor—Gabapentin—epilepsy syndrome	1.67e-05	0.000174	CcSEcCtD
Trazodone—Rash—Diazepam—epilepsy syndrome	1.67e-05	0.000173	CcSEcCtD
Trazodone—Dermatitis—Diazepam—epilepsy syndrome	1.67e-05	0.000173	CcSEcCtD
Trazodone—Visual impairment—Topiramate—epilepsy syndrome	1.66e-05	0.000173	CcSEcCtD
Trazodone—Quetiapine—CYP2C19—epilepsy syndrome	1.66e-05	0.00805	CrCbGaD
Trazodone—Chest pain—Pregabalin—epilepsy syndrome	1.66e-05	0.000172	CcSEcCtD
Trazodone—Myalgia—Pregabalin—epilepsy syndrome	1.66e-05	0.000172	CcSEcCtD
Trazodone—Arthralgia—Pregabalin—epilepsy syndrome	1.66e-05	0.000172	CcSEcCtD
Trazodone—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.66e-05	0.000172	CcSEcCtD
Trazodone—Dizziness—Zonisamide—epilepsy syndrome	1.66e-05	0.000172	CcSEcCtD
Trazodone—Headache—Diazepam—epilepsy syndrome	1.66e-05	0.000172	CcSEcCtD
Trazodone—Anxiety—Pregabalin—epilepsy syndrome	1.65e-05	0.000171	CcSEcCtD
Trazodone—Diarrhoea—Clonazepam—epilepsy syndrome	1.65e-05	0.000171	CcSEcCtD
Trazodone—Anaemia—Gabapentin—epilepsy syndrome	1.65e-05	0.000171	CcSEcCtD
Trazodone—Hypotension—Valproic Acid—epilepsy syndrome	1.64e-05	0.00017	CcSEcCtD
Trazodone—Asthenia—Carbamazepine—epilepsy syndrome	1.64e-05	0.00017	CcSEcCtD
Trazodone—Agitation—Gabapentin—epilepsy syndrome	1.64e-05	0.00017	CcSEcCtD
Trazodone—Diarrhoea—Phenytoin—epilepsy syndrome	1.64e-05	0.00017	CcSEcCtD
Trazodone—Discomfort—Pregabalin—epilepsy syndrome	1.64e-05	0.00017	CcSEcCtD
Trazodone—Nausea—Fosphenytoin—epilepsy syndrome	1.64e-05	0.00017	CcSEcCtD
Trazodone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.63e-05	0.000169	CcSEcCtD
Trazodone—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.63e-05	0.000169	CcSEcCtD
Trazodone—Vomiting—Felbamate—epilepsy syndrome	1.63e-05	0.000169	CcSEcCtD
Trazodone—Dry mouth—Pregabalin—epilepsy syndrome	1.62e-05	0.000168	CcSEcCtD
Trazodone—Pruritus—Carbamazepine—epilepsy syndrome	1.62e-05	0.000168	CcSEcCtD
Trazodone—Rash—Felbamate—epilepsy syndrome	1.62e-05	0.000167	CcSEcCtD
Trazodone—Dermatitis—Felbamate—epilepsy syndrome	1.61e-05	0.000167	CcSEcCtD
Trazodone—Malaise—Gabapentin—epilepsy syndrome	1.61e-05	0.000167	CcSEcCtD
Trazodone—Tinnitus—Topiramate—epilepsy syndrome	1.61e-05	0.000167	CcSEcCtD
Trazodone—Vertigo—Gabapentin—epilepsy syndrome	1.61e-05	0.000167	CcSEcCtD
Trazodone—Headache—Felbamate—epilepsy syndrome	1.6e-05	0.000166	CcSEcCtD
Trazodone—Confusional state—Pregabalin—epilepsy syndrome	1.6e-05	0.000166	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.6e-05	0.000166	CcSEcCtD
Trazodone—Flushing—Topiramate—epilepsy syndrome	1.6e-05	0.000166	CcSEcCtD
Trazodone—Syncope—Gabapentin—epilepsy syndrome	1.6e-05	0.000166	CcSEcCtD
Trazodone—Dizziness—Clonazepam—epilepsy syndrome	1.6e-05	0.000166	CcSEcCtD
Trazodone—Nausea—Vigabatrin—epilepsy syndrome	1.6e-05	0.000166	CcSEcCtD
Trazodone—Vomiting—Zonisamide—epilepsy syndrome	1.59e-05	0.000165	CcSEcCtD
Trazodone—Insomnia—Valproic Acid—epilepsy syndrome	1.59e-05	0.000165	CcSEcCtD
Trazodone—Oedema—Pregabalin—epilepsy syndrome	1.59e-05	0.000165	CcSEcCtD
Trazodone—Asthenia—Lamotrigine—epilepsy syndrome	1.59e-05	0.000165	CcSEcCtD
Trazodone—Fluphenazine—CYP2D6—epilepsy syndrome	1.59e-05	0.00769	CrCbGaD
Trazodone—Dizziness—Phenytoin—epilepsy syndrome	1.59e-05	0.000165	CcSEcCtD
Trazodone—Rash—Zonisamide—epilepsy syndrome	1.58e-05	0.000164	CcSEcCtD
Trazodone—Paraesthesia—Valproic Acid—epilepsy syndrome	1.58e-05	0.000164	CcSEcCtD
Trazodone—Palpitations—Gabapentin—epilepsy syndrome	1.58e-05	0.000164	CcSEcCtD
Trazodone—Dermatitis—Zonisamide—epilepsy syndrome	1.58e-05	0.000164	CcSEcCtD
Trazodone—Dizziness—Oxcarbazepine—epilepsy syndrome	1.58e-05	0.000164	CcSEcCtD
Trazodone—Nausea—Diazepam—epilepsy syndrome	1.57e-05	0.000163	CcSEcCtD
Trazodone—Loss of consciousness—Gabapentin—epilepsy syndrome	1.57e-05	0.000163	CcSEcCtD
Trazodone—Headache—Zonisamide—epilepsy syndrome	1.57e-05	0.000163	CcSEcCtD
Trazodone—Dyspnoea—Valproic Acid—epilepsy syndrome	1.57e-05	0.000163	CcSEcCtD
Trazodone—Diarrhoea—Carbamazepine—epilepsy syndrome	1.57e-05	0.000163	CcSEcCtD
Trazodone—Pruritus—Lamotrigine—epilepsy syndrome	1.57e-05	0.000162	CcSEcCtD
Trazodone—Shock—Pregabalin—epilepsy syndrome	1.57e-05	0.000162	CcSEcCtD
Trazodone—Somnolence—Valproic Acid—epilepsy syndrome	1.56e-05	0.000162	CcSEcCtD
Trazodone—Tachycardia—Pregabalin—epilepsy syndrome	1.55e-05	0.000161	CcSEcCtD
Trazodone—Chills—Topiramate—epilepsy syndrome	1.55e-05	0.000161	CcSEcCtD
Trazodone—Hypertension—Gabapentin—epilepsy syndrome	1.54e-05	0.00016	CcSEcCtD
Trazodone—Hyperhidrosis—Pregabalin—epilepsy syndrome	1.54e-05	0.000159	CcSEcCtD
Trazodone—Vomiting—Clonazepam—epilepsy syndrome	1.54e-05	0.000159	CcSEcCtD
Trazodone—Decreased appetite—Valproic Acid—epilepsy syndrome	1.53e-05	0.000159	CcSEcCtD
Trazodone—Alopecia—Topiramate—epilepsy syndrome	1.53e-05	0.000158	CcSEcCtD
Trazodone—Vomiting—Phenytoin—epilepsy syndrome	1.53e-05	0.000158	CcSEcCtD
Trazodone—Rash—Clonazepam—epilepsy syndrome	1.52e-05	0.000158	CcSEcCtD
Trazodone—Dermatitis—Clonazepam—epilepsy syndrome	1.52e-05	0.000158	CcSEcCtD
Trazodone—Chest pain—Gabapentin—epilepsy syndrome	1.52e-05	0.000158	CcSEcCtD
Trazodone—Arthralgia—Gabapentin—epilepsy syndrome	1.52e-05	0.000158	CcSEcCtD
Trazodone—Myalgia—Gabapentin—epilepsy syndrome	1.52e-05	0.000158	CcSEcCtD
Trazodone—Nausea—Felbamate—epilepsy syndrome	1.52e-05	0.000158	CcSEcCtD
Trazodone—Vomiting—Oxcarbazepine—epilepsy syndrome	1.52e-05	0.000157	CcSEcCtD
Trazodone—Fatigue—Valproic Acid—epilepsy syndrome	1.52e-05	0.000157	CcSEcCtD
Trazodone—Anxiety—Gabapentin—epilepsy syndrome	1.52e-05	0.000157	CcSEcCtD
Trazodone—Anorexia—Pregabalin—epilepsy syndrome	1.52e-05	0.000157	CcSEcCtD
Trazodone—Dizziness—Carbamazepine—epilepsy syndrome	1.52e-05	0.000157	CcSEcCtD
Trazodone—Diarrhoea—Lamotrigine—epilepsy syndrome	1.52e-05	0.000157	CcSEcCtD
Trazodone—Headache—Clonazepam—epilepsy syndrome	1.51e-05	0.000157	CcSEcCtD
Trazodone—Rash—Phenytoin—epilepsy syndrome	1.51e-05	0.000157	CcSEcCtD
Trazodone—Nefazodone—ABCB1—epilepsy syndrome	1.51e-05	0.00733	CrCbGaD
Trazodone—Dermatitis—Phenytoin—epilepsy syndrome	1.51e-05	0.000157	CcSEcCtD
Trazodone—Rash—Oxcarbazepine—epilepsy syndrome	1.51e-05	0.000156	CcSEcCtD
Trazodone—Pain—Valproic Acid—epilepsy syndrome	1.5e-05	0.000156	CcSEcCtD
Trazodone—Constipation—Valproic Acid—epilepsy syndrome	1.5e-05	0.000156	CcSEcCtD
Trazodone—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.5e-05	0.000156	CcSEcCtD
Trazodone—Headache—Phenytoin—epilepsy syndrome	1.5e-05	0.000156	CcSEcCtD
Trazodone—Discomfort—Gabapentin—epilepsy syndrome	1.5e-05	0.000156	CcSEcCtD
Trazodone—Headache—Oxcarbazepine—epilepsy syndrome	1.5e-05	0.000155	CcSEcCtD
Trazodone—Nausea—Zonisamide—epilepsy syndrome	1.49e-05	0.000154	CcSEcCtD
Trazodone—Dry mouth—Gabapentin—epilepsy syndrome	1.49e-05	0.000154	CcSEcCtD
Trazodone—Hypotension—Pregabalin—epilepsy syndrome	1.49e-05	0.000154	CcSEcCtD
Trazodone—Flatulence—Topiramate—epilepsy syndrome	1.48e-05	0.000154	CcSEcCtD
Trazodone—Tension—Topiramate—epilepsy syndrome	1.48e-05	0.000153	CcSEcCtD
Trazodone—Dysgeusia—Topiramate—epilepsy syndrome	1.47e-05	0.000153	CcSEcCtD
Trazodone—Confusional state—Gabapentin—epilepsy syndrome	1.47e-05	0.000153	CcSEcCtD
Trazodone—Dizziness—Lamotrigine—epilepsy syndrome	1.46e-05	0.000152	CcSEcCtD
Trazodone—Nervousness—Topiramate—epilepsy syndrome	1.46e-05	0.000151	CcSEcCtD
Trazodone—Oedema—Gabapentin—epilepsy syndrome	1.46e-05	0.000151	CcSEcCtD
Trazodone—Vomiting—Carbamazepine—epilepsy syndrome	1.46e-05	0.000151	CcSEcCtD
Trazodone—Back pain—Topiramate—epilepsy syndrome	1.45e-05	0.000151	CcSEcCtD
Trazodone—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.45e-05	0.00015	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	1.45e-05	0.00015	CcSEcCtD
Trazodone—Rash—Carbamazepine—epilepsy syndrome	1.44e-05	0.00015	CcSEcCtD
Trazodone—Dermatitis—Carbamazepine—epilepsy syndrome	1.44e-05	0.00015	CcSEcCtD
Trazodone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.44e-05	0.000149	CcSEcCtD
Trazodone—Insomnia—Pregabalin—epilepsy syndrome	1.44e-05	0.000149	CcSEcCtD
Trazodone—Nausea—Clonazepam—epilepsy syndrome	1.44e-05	0.000149	CcSEcCtD
Trazodone—Headache—Carbamazepine—epilepsy syndrome	1.44e-05	0.000149	CcSEcCtD
Trazodone—Shock—Gabapentin—epilepsy syndrome	1.44e-05	0.000149	CcSEcCtD
Trazodone—Paraesthesia—Pregabalin—epilepsy syndrome	1.43e-05	0.000148	CcSEcCtD
Trazodone—Clozapine—CYP2C19—epilepsy syndrome	1.43e-05	0.00692	CrCbGaD
Trazodone—Nausea—Phenytoin—epilepsy syndrome	1.43e-05	0.000148	CcSEcCtD
Trazodone—Tachycardia—Gabapentin—epilepsy syndrome	1.42e-05	0.000148	CcSEcCtD
Trazodone—Dyspnoea—Pregabalin—epilepsy syndrome	1.42e-05	0.000147	CcSEcCtD
Trazodone—Nausea—Oxcarbazepine—epilepsy syndrome	1.42e-05	0.000147	CcSEcCtD
Trazodone—Vision blurred—Topiramate—epilepsy syndrome	1.42e-05	0.000147	CcSEcCtD
Trazodone—Somnolence—Pregabalin—epilepsy syndrome	1.41e-05	0.000147	CcSEcCtD
Trazodone—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.41e-05	0.000146	CcSEcCtD
Trazodone—Tremor—Topiramate—epilepsy syndrome	1.41e-05	0.000146	CcSEcCtD
Trazodone—Vomiting—Lamotrigine—epilepsy syndrome	1.41e-05	0.000146	CcSEcCtD
Trazodone—Aripiprazole—ABCB1—epilepsy syndrome	1.41e-05	0.00681	CrCbGaD
Trazodone—Urticaria—Valproic Acid—epilepsy syndrome	1.4e-05	0.000145	CcSEcCtD
Trazodone—Thioproperazine—ALB—epilepsy syndrome	1.4e-05	0.00677	CrCbGaD
Trazodone—Rash—Lamotrigine—epilepsy syndrome	1.4e-05	0.000145	CcSEcCtD
Trazodone—Ill-defined disorder—Topiramate—epilepsy syndrome	1.4e-05	0.000145	CcSEcCtD
Trazodone—Dermatitis—Lamotrigine—epilepsy syndrome	1.4e-05	0.000145	CcSEcCtD
Trazodone—Abdominal pain—Valproic Acid—epilepsy syndrome	1.39e-05	0.000144	CcSEcCtD
Trazodone—Body temperature increased—Valproic Acid—epilepsy syndrome	1.39e-05	0.000144	CcSEcCtD
Trazodone—Anorexia—Gabapentin—epilepsy syndrome	1.39e-05	0.000144	CcSEcCtD
Trazodone—Anaemia—Topiramate—epilepsy syndrome	1.39e-05	0.000144	CcSEcCtD
Trazodone—Trifluoperazine—HTR2A—epilepsy syndrome	1.39e-05	0.00672	CrCbGaD
Trazodone—Headache—Lamotrigine—epilepsy syndrome	1.39e-05	0.000144	CcSEcCtD
Trazodone—Decreased appetite—Pregabalin—epilepsy syndrome	1.38e-05	0.000143	CcSEcCtD
Trazodone—Agitation—Topiramate—epilepsy syndrome	1.38e-05	0.000143	CcSEcCtD
Trazodone—Loxapine—HTR2A—epilepsy syndrome	1.38e-05	0.00668	CrCbGaD
Trazodone—Perphenazine—HTR2A—epilepsy syndrome	1.37e-05	0.00665	CrCbGaD
Trazodone—Fatigue—Pregabalin—epilepsy syndrome	1.37e-05	0.000142	CcSEcCtD
Trazodone—Hypotension—Gabapentin—epilepsy syndrome	1.36e-05	0.000141	CcSEcCtD
Trazodone—Nausea—Carbamazepine—epilepsy syndrome	1.36e-05	0.000141	CcSEcCtD
Trazodone—Pain—Pregabalin—epilepsy syndrome	1.36e-05	0.000141	CcSEcCtD
Trazodone—Constipation—Pregabalin—epilepsy syndrome	1.36e-05	0.000141	CcSEcCtD
Trazodone—Malaise—Topiramate—epilepsy syndrome	1.36e-05	0.000141	CcSEcCtD
Trazodone—Vertigo—Topiramate—epilepsy syndrome	1.35e-05	0.00014	CcSEcCtD
Trazodone—Syncope—Topiramate—epilepsy syndrome	1.35e-05	0.00014	CcSEcCtD
Trazodone—Quetiapine—HTR2A—epilepsy syndrome	1.35e-05	0.00652	CrCbGaD
Trazodone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	1.33e-05	0.000138	CcSEcCtD
Trazodone—Palpitations—Topiramate—epilepsy syndrome	1.33e-05	0.000138	CcSEcCtD
Trazodone—Loss of consciousness—Topiramate—epilepsy syndrome	1.32e-05	0.000137	CcSEcCtD
Trazodone—Insomnia—Gabapentin—epilepsy syndrome	1.32e-05	0.000137	CcSEcCtD
Trazodone—Nausea—Lamotrigine—epilepsy syndrome	1.32e-05	0.000136	CcSEcCtD
Trazodone—Feeling abnormal—Pregabalin—epilepsy syndrome	1.31e-05	0.000136	CcSEcCtD
Trazodone—Paraesthesia—Gabapentin—epilepsy syndrome	1.31e-05	0.000136	CcSEcCtD
Trazodone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.3e-05	0.000135	CcSEcCtD
Trazodone—Dyspnoea—Gabapentin—epilepsy syndrome	1.3e-05	0.000135	CcSEcCtD
Trazodone—Hypertension—Topiramate—epilepsy syndrome	1.3e-05	0.000135	CcSEcCtD
Trazodone—Somnolence—Gabapentin—epilepsy syndrome	1.3e-05	0.000134	CcSEcCtD
Trazodone—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.3e-05	0.000134	CcSEcCtD
Trazodone—Myalgia—Topiramate—epilepsy syndrome	1.28e-05	0.000133	CcSEcCtD
Trazodone—Chest pain—Topiramate—epilepsy syndrome	1.28e-05	0.000133	CcSEcCtD
Trazodone—Arthralgia—Topiramate—epilepsy syndrome	1.28e-05	0.000133	CcSEcCtD
Trazodone—Anxiety—Topiramate—epilepsy syndrome	1.28e-05	0.000132	CcSEcCtD
Trazodone—Decreased appetite—Gabapentin—epilepsy syndrome	1.27e-05	0.000131	CcSEcCtD
Trazodone—Discomfort—Topiramate—epilepsy syndrome	1.26e-05	0.000131	CcSEcCtD
Trazodone—Urticaria—Pregabalin—epilepsy syndrome	1.26e-05	0.000131	CcSEcCtD
Trazodone—Asthenia—Valproic Acid—epilepsy syndrome	1.26e-05	0.000131	CcSEcCtD
Trazodone—Fatigue—Gabapentin—epilepsy syndrome	1.26e-05	0.00013	CcSEcCtD
Trazodone—Abdominal pain—Pregabalin—epilepsy syndrome	1.26e-05	0.00013	CcSEcCtD
Trazodone—Body temperature increased—Pregabalin—epilepsy syndrome	1.26e-05	0.00013	CcSEcCtD
Trazodone—Perphenazine—CYP2D6—epilepsy syndrome	1.26e-05	0.00608	CrCbGaD
Trazodone—Dry mouth—Topiramate—epilepsy syndrome	1.25e-05	0.00013	CcSEcCtD
Trazodone—Constipation—Gabapentin—epilepsy syndrome	1.25e-05	0.000129	CcSEcCtD
Trazodone—Pain—Gabapentin—epilepsy syndrome	1.25e-05	0.000129	CcSEcCtD
Trazodone—Pruritus—Valproic Acid—epilepsy syndrome	1.25e-05	0.000129	CcSEcCtD
Trazodone—Confusional state—Topiramate—epilepsy syndrome	1.24e-05	0.000128	CcSEcCtD
Trazodone—Quetiapine—CYP2D6—epilepsy syndrome	1.23e-05	0.00596	CrCbGaD
Trazodone—Oedema—Topiramate—epilepsy syndrome	1.23e-05	0.000127	CcSEcCtD
Trazodone—Shock—Topiramate—epilepsy syndrome	1.21e-05	0.000125	CcSEcCtD
Trazodone—Diarrhoea—Valproic Acid—epilepsy syndrome	1.2e-05	0.000125	CcSEcCtD
Trazodone—Feeling abnormal—Gabapentin—epilepsy syndrome	1.2e-05	0.000125	CcSEcCtD
Trazodone—Tachycardia—Topiramate—epilepsy syndrome	1.2e-05	0.000124	CcSEcCtD
Trazodone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.19e-05	0.000124	CcSEcCtD
Trazodone—Hyperhidrosis—Topiramate—epilepsy syndrome	1.19e-05	0.000123	CcSEcCtD
Trazodone—Hypersensitivity—Pregabalin—epilepsy syndrome	1.17e-05	0.000122	CcSEcCtD
Trazodone—Anorexia—Topiramate—epilepsy syndrome	1.17e-05	0.000121	CcSEcCtD
Trazodone—Dizziness—Valproic Acid—epilepsy syndrome	1.16e-05	0.000121	CcSEcCtD
Trazodone—Urticaria—Gabapentin—epilepsy syndrome	1.16e-05	0.00012	CcSEcCtD
Trazodone—Clozapine—HTR2A—epilepsy syndrome	1.16e-05	0.00561	CrCbGaD
Trazodone—Abdominal pain—Gabapentin—epilepsy syndrome	1.15e-05	0.00012	CcSEcCtD
Trazodone—Body temperature increased—Gabapentin—epilepsy syndrome	1.15e-05	0.00012	CcSEcCtD
Trazodone—Hypotension—Topiramate—epilepsy syndrome	1.15e-05	0.000119	CcSEcCtD
Trazodone—Asthenia—Pregabalin—epilepsy syndrome	1.14e-05	0.000118	CcSEcCtD
Trazodone—Fluphenazine—ABCB1—epilepsy syndrome	1.13e-05	0.00549	CrCbGaD
Trazodone—Pruritus—Pregabalin—epilepsy syndrome	1.13e-05	0.000117	CcSEcCtD
Trazodone—Vomiting—Valproic Acid—epilepsy syndrome	1.12e-05	0.000116	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.12e-05	0.000116	CcSEcCtD
Trazodone—Insomnia—Topiramate—epilepsy syndrome	1.11e-05	0.000115	CcSEcCtD
Trazodone—Rash—Valproic Acid—epilepsy syndrome	1.11e-05	0.000115	CcSEcCtD
Trazodone—Dermatitis—Valproic Acid—epilepsy syndrome	1.11e-05	0.000115	CcSEcCtD
Trazodone—Headache—Valproic Acid—epilepsy syndrome	1.1e-05	0.000114	CcSEcCtD
Trazodone—Paraesthesia—Topiramate—epilepsy syndrome	1.1e-05	0.000114	CcSEcCtD
Trazodone—Dyspnoea—Topiramate—epilepsy syndrome	1.09e-05	0.000113	CcSEcCtD
Trazodone—Somnolence—Topiramate—epilepsy syndrome	1.09e-05	0.000113	CcSEcCtD
Trazodone—Diarrhoea—Pregabalin—epilepsy syndrome	1.09e-05	0.000113	CcSEcCtD
Trazodone—Hypersensitivity—Gabapentin—epilepsy syndrome	1.07e-05	0.000111	CcSEcCtD
Trazodone—Decreased appetite—Topiramate—epilepsy syndrome	1.07e-05	0.000111	CcSEcCtD
Trazodone—Clozapine—CYP2D6—epilepsy syndrome	1.06e-05	0.00513	CrCbGaD
Trazodone—Fatigue—Topiramate—epilepsy syndrome	1.06e-05	0.00011	CcSEcCtD
Trazodone—Dizziness—Pregabalin—epilepsy syndrome	1.05e-05	0.000109	CcSEcCtD
Trazodone—Pain—Topiramate—epilepsy syndrome	1.05e-05	0.000109	CcSEcCtD
Trazodone—Constipation—Topiramate—epilepsy syndrome	1.05e-05	0.000109	CcSEcCtD
Trazodone—Asthenia—Gabapentin—epilepsy syndrome	1.05e-05	0.000109	CcSEcCtD
Trazodone—Nausea—Valproic Acid—epilepsy syndrome	1.05e-05	0.000108	CcSEcCtD
Trazodone—Pruritus—Gabapentin—epilepsy syndrome	1.03e-05	0.000107	CcSEcCtD
Trazodone—Vomiting—Pregabalin—epilepsy syndrome	1.01e-05	0.000105	CcSEcCtD
Trazodone—Feeling abnormal—Topiramate—epilepsy syndrome	1.01e-05	0.000105	CcSEcCtD
Trazodone—Gastrointestinal pain—Topiramate—epilepsy syndrome	1e-05	0.000104	CcSEcCtD
Trazodone—Rash—Pregabalin—epilepsy syndrome	1e-05	0.000104	CcSEcCtD
Trazodone—Dermatitis—Pregabalin—epilepsy syndrome	1e-05	0.000104	CcSEcCtD
Trazodone—Diarrhoea—Gabapentin—epilepsy syndrome	9.98e-06	0.000103	CcSEcCtD
Trazodone—Headache—Pregabalin—epilepsy syndrome	9.97e-06	0.000103	CcSEcCtD
Trazodone—Urticaria—Topiramate—epilepsy syndrome	9.75e-06	0.000101	CcSEcCtD
Trazodone—Abdominal pain—Topiramate—epilepsy syndrome	9.7e-06	0.000101	CcSEcCtD
Trazodone—Body temperature increased—Topiramate—epilepsy syndrome	9.7e-06	0.000101	CcSEcCtD
Trazodone—Dizziness—Gabapentin—epilepsy syndrome	9.65e-06	0.0001	CcSEcCtD
Trazodone—Nausea—Pregabalin—epilepsy syndrome	9.45e-06	9.8e-05	CcSEcCtD
Trazodone—Vomiting—Gabapentin—epilepsy syndrome	9.28e-06	9.62e-05	CcSEcCtD
Trazodone—Rash—Gabapentin—epilepsy syndrome	9.2e-06	9.54e-05	CcSEcCtD
Trazodone—Dermatitis—Gabapentin—epilepsy syndrome	9.19e-06	9.53e-05	CcSEcCtD
Trazodone—Headache—Gabapentin—epilepsy syndrome	9.14e-06	9.48e-05	CcSEcCtD
Trazodone—Trifluoperazine—ABCB1—epilepsy syndrome	9.06e-06	0.00439	CrCbGaD
Trazodone—Hypersensitivity—Topiramate—epilepsy syndrome	9.04e-06	9.38e-05	CcSEcCtD
Trazodone—Asthenia—Topiramate—epilepsy syndrome	8.81e-06	9.13e-05	CcSEcCtD
Trazodone—Quetiapine—ABCB1—epilepsy syndrome	8.79e-06	0.00426	CrCbGaD
Trazodone—Pruritus—Topiramate—epilepsy syndrome	8.68e-06	9e-05	CcSEcCtD
Trazodone—Nausea—Gabapentin—epilepsy syndrome	8.67e-06	8.98e-05	CcSEcCtD
Trazodone—Diarrhoea—Topiramate—epilepsy syndrome	8.4e-06	8.71e-05	CcSEcCtD
Trazodone—Dizziness—Topiramate—epilepsy syndrome	8.12e-06	8.42e-05	CcSEcCtD
Trazodone—Vomiting—Topiramate—epilepsy syndrome	7.8e-06	8.09e-05	CcSEcCtD
Trazodone—Rash—Topiramate—epilepsy syndrome	7.74e-06	8.02e-05	CcSEcCtD
Trazodone—Dermatitis—Topiramate—epilepsy syndrome	7.73e-06	8.02e-05	CcSEcCtD
Trazodone—Headache—Topiramate—epilepsy syndrome	7.69e-06	7.97e-05	CcSEcCtD
Trazodone—Clozapine—ABCB1—epilepsy syndrome	7.56e-06	0.00366	CrCbGaD
Trazodone—Nausea—Topiramate—epilepsy syndrome	7.29e-06	7.56e-05	CcSEcCtD
Trazodone—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.49e-06	3.92e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.49e-06	3.91e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	1.49e-06	3.91e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	1.48e-06	3.89e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.48e-06	3.89e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.48e-06	3.89e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.48e-06	3.89e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.47e-06	3.87e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	1.47e-06	3.87e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.47e-06	3.86e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.46e-06	3.84e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.45e-06	3.81e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GPX1—epilepsy syndrome	1.44e-06	3.79e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	1.44e-06	3.79e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	1.44e-06	3.79e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.44e-06	3.77e-05	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.43e-06	3.76e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.43e-06	3.76e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.42e-06	3.74e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.42e-06	3.74e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.42e-06	3.73e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.41e-06	3.71e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	1.4e-06	3.68e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	1.4e-06	3.67e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	1.39e-06	3.66e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.39e-06	3.65e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.39e-06	3.64e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.38e-06	3.64e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	1.37e-06	3.59e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.36e-06	3.58e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.36e-06	3.57e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	1.35e-06	3.56e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.35e-06	3.55e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.35e-06	3.55e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.35e-06	3.54e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.35e-06	3.54e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.35e-06	3.54e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.35e-06	3.54e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.35e-06	3.54e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.35e-06	3.54e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.34e-06	3.53e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.34e-06	3.53e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.34e-06	3.53e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.34e-06	3.52e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.34e-06	3.52e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TH—epilepsy syndrome	1.34e-06	3.52e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.34e-06	3.52e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.33e-06	3.48e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.32e-06	3.47e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.32e-06	3.47e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.32e-06	3.46e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.32e-06	3.46e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.31e-06	3.45e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.3e-06	3.42e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.3e-06	3.41e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.3e-06	3.41e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.3e-06	3.41e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.29e-06	3.39e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.29e-06	3.38e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.28e-06	3.38e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.28e-06	3.37e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.28e-06	3.36e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.27e-06	3.35e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.27e-06	3.33e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.27e-06	3.33e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.26e-06	3.32e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TH—epilepsy syndrome	1.26e-06	3.32e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.26e-06	3.31e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.25e-06	3.29e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.25e-06	3.28e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.24e-06	3.27e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.24e-06	3.26e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.24e-06	3.25e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.24e-06	3.25e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	1.23e-06	3.24e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.23e-06	3.24e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.23e-06	3.24e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.23e-06	3.23e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.23e-06	3.22e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.23e-06	3.22e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.22e-06	3.22e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.22e-06	3.21e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.2e-06	3.15e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.18e-06	3.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.17e-06	3.08e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	1.16e-06	3.06e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	1.16e-06	3.05e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.16e-06	3.05e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.16e-06	3.05e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.16e-06	3.05e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	1.15e-06	3.01e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.14e-06	2.99e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.14e-06	2.99e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.14e-06	2.99e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.14e-06	2.99e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.14e-06	2.99e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.14e-06	2.98e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.13e-06	2.98e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.13e-06	2.96e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	1.12e-06	2.95e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.12e-06	2.94e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.12e-06	2.93e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.12e-06	2.93e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.11e-06	2.93e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.11e-06	2.93e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.11e-06	2.91e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CAT—epilepsy syndrome	1.1e-06	2.9e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.1e-06	2.9e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.09e-06	2.87e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	2.83e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.07e-06	2.82e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.07e-06	2.82e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.07e-06	2.81e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.07e-06	2.8e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.06e-06	2.8e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.06e-06	2.78e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.06e-06	2.78e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.06e-06	2.78e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.05e-06	2.77e-05	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.05e-06	2.77e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.05e-06	2.76e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.05e-06	2.75e-05	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.04e-06	2.74e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.04e-06	2.73e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.04e-06	2.72e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	1.03e-06	2.72e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.03e-06	2.71e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.03e-06	2.7e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.01e-06	2.67e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.01e-06	2.66e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	1e-06	2.64e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1e-06	2.63e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GPX1—epilepsy syndrome	9.97e-07	2.62e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	9.96e-07	2.62e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	9.78e-07	2.57e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	9.77e-07	2.57e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	9.77e-07	2.57e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—POMC—epilepsy syndrome	9.76e-07	2.57e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—POMC—epilepsy syndrome	9.75e-07	2.56e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	9.73e-07	2.56e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ALB—epilepsy syndrome	9.7e-07	2.55e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	9.58e-07	2.52e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	9.57e-07	2.52e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	9.55e-07	2.51e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	9.48e-07	2.49e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	9.4e-07	2.47e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	9.37e-07	2.46e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	9.3e-07	2.44e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	9.26e-07	2.43e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	9.25e-07	2.43e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	9.12e-07	2.4e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	9.07e-07	2.38e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	9.01e-07	2.37e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	8.9e-07	2.34e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ALB—epilepsy syndrome	8.89e-07	2.34e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	8.81e-07	2.32e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	8.77e-07	2.31e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	8.77e-07	2.31e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AGT—epilepsy syndrome	8.74e-07	2.3e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	8.71e-07	2.29e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	8.65e-07	2.27e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	8.63e-07	2.27e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOE—epilepsy syndrome	8.57e-07	2.25e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	8.49e-07	2.23e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	8.47e-07	2.23e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.46e-07	2.22e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	8.42e-07	2.21e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	8.38e-07	2.2e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	8.37e-07	2.2e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	8.34e-07	2.19e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	8.28e-07	2.18e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TH—epilepsy syndrome	8.25e-07	2.17e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AGT—epilepsy syndrome	8.24e-07	2.17e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	8.14e-07	2.14e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	8.1e-07	2.13e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOE—epilepsy syndrome	8.07e-07	2.12e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	8.03e-07	2.11e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RELA—epilepsy syndrome	8.01e-07	2.11e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	7.92e-07	2.08e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	7.88e-07	2.07e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	7.87e-07	2.07e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	7.87e-07	2.07e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	7.86e-07	2.07e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	7.86e-07	2.07e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	7.78e-07	2.04e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	7.71e-07	2.03e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	7.68e-07	2.02e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	7.64e-07	2.01e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—POMC—epilepsy syndrome	7.36e-07	1.93e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.31e-07	1.92e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	7.31e-07	1.92e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	7.3e-07	1.92e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.29e-07	1.92e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	7.27e-07	1.91e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	7.24e-07	1.9e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	7.23e-07	1.9e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	7.16e-07	1.88e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.16e-07	1.88e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.11e-07	1.87e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	7.09e-07	1.86e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	7.08e-07	1.86e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	7.04e-07	1.85e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JUN—epilepsy syndrome	7.02e-07	1.84e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.94e-07	1.82e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	6.89e-07	1.81e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.89e-07	1.81e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	6.84e-07	1.8e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	6.83e-07	1.79e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.79e-07	1.79e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—epilepsy syndrome	6.71e-07	1.76e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	6.7e-07	1.76e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.65e-07	1.75e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	6.64e-07	1.74e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	6.62e-07	1.74e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	6.61e-07	1.74e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	6.59e-07	1.73e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	6.5e-07	1.71e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	6.4e-07	1.68e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—epilepsy syndrome	6.32e-07	1.66e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	6.31e-07	1.66e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SRC—epilepsy syndrome	6.3e-07	1.65e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	6.23e-07	1.64e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	6.18e-07	1.62e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	6.15e-07	1.62e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	6.14e-07	1.61e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	6.13e-07	1.61e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	6.04e-07	1.59e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	6.02e-07	1.58e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—epilepsy syndrome	5.87e-07	1.54e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	5.74e-07	1.51e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	5.6e-07	1.47e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.59e-07	1.47e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.53e-07	1.45e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	5.41e-07	1.42e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AGT—epilepsy syndrome	5.39e-07	1.42e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOE—epilepsy syndrome	5.28e-07	1.39e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	4.54e-07	1.19e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.53e-07	1.19e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	4.52e-07	1.19e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—epilepsy syndrome	4.27e-07	1.12e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.13e-07	1.09e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.92e-07	1.03e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	3.91e-07	1.03e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.91e-07	1.03e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	3.84e-07	1.01e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.62e-07	9.5e-06	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	3.57e-07	9.38e-06	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.95e-07	7.75e-06	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.78e-07	7.31e-06	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.82e-07	4.78e-06	CbGpPWpGaD
